Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :18987736
Publication Date : //

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.


Acute myeloid leukaemia is a highly malignant haematopoietic tumour that affects about 13,000 adults in the United States each year. The treatment of this disease has changed little in the past two decades, because most of the genetic events that initiate the disease remain undiscovered. Whole-genome sequencing is now possible at a reasonable cost and timeframe to use this approach for the unbiased discovery of tumour-specific somatic mutations that alter the protein-coding genes. Here we present the results obtained from sequencing a typical acute myeloid leukaemia genome, and its matched normal counterpart obtained from the same patient's skin. We discovered ten genes with acquired mutations; two were previously described mutations that are thought to contribute to tumour progression, and eight were new mutations present in virtually all tumour cells at presentation and relapse, the function of which is not yet known. Our study establishes whole-genome sequencing as an unbiased method for discovering cancer-initiating mutations in previously unidentified genes that may respond to targeted therapies.

Authors : Ley Timothy J , Mardis Elaine R , Ding Li , Fulton Bob , McLellan Michael D , Chen Ken , Dooling David , Dunford-Shore Brian H , McGrath Sean , Hickenbotham Matthew , Cook Lisa , Abbott Rachel , Larson David E , Koboldt Dan C , Pohl Craig , Smith Scott , Hawkins Amy , Abbott Scott , Locke Devin , Hillier Ladeana W , Miner Tracie , Fulton Lucinda , Magrini Vincent , Wylie Todd , Glasscock Jarret , Conyers Joshua , Sander Nathan , Shi Xiaoqi , Osborne John R , Minx Patrick , Gordon David , Chinwalla Asif , Zhao Yu , Ries Rhonda E , Payton Jacqueline E , Westervelt Peter , Tomasson Michael H , Watson Mark , Baty Jack , Ivanovich Jennifer , Heath Sharon , Shannon William D , Nagarajan Rakesh , Walter Matthew J , Link Daniel C , Graubert Timothy A , DiPersio John F , Wilson Richard K ,

Related products :

Catalog number Product name Quantity
orb61206 AC220 Quizartinib (AC220) is a small molecule receptor tyrosine kinase inhibitor that is currently under development for the treatment of acute myeloid leukaemia. For research use only. 500 mg
T18-019-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-015-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-017-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-018-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-019-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-012-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-019-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-012-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-017-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-018-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-015-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-020-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-018-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-020-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-020-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-012-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-015-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-018-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-019-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-016-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-013-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-013-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-013-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-013-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur